India’s Gem Aromatics IPO has been subscribed 1.6 times on Day 2, with strong retail and institutional participation. The grey market premium (GMP) stands at 8%, reflecting cautious optimism ahead of listing.
The Gem Aromatics initial public offering (IPO) has drawn strong investor interest, reaching 1.6 times subscription on the second day of bidding. The offering, which seeks to raise over USD 54 million (₹451 crore), reflects solid demand from both retail and institutional categories.
Retail investors subscribed their portion nearly twice, while Non-Institutional Investors oversubscribed by 1.6 times. Qualified Institutional Buyers have also fully taken up their reserved allocation, highlighting confidence in the company’s growth outlook.
The IPO, priced in the range of ₹309–₹325 per share, requires a minimum bid of 46 shares, amounting to an investment of around USD 180 (₹14,950) at the upper end. The subscription window runs from August 19 to August 21, with allotments likely finalized by August 22. Shares are expected to list on stock exchanges on August 26.
Grey Market Premium (GMP) Trends
Ahead of listing, unlisted shares of Gem Aromatics are trading at an 8% premium, around ₹351 per share. While this reflects a decline from earlier higher premiums, analysts note that sustained GMP indicates steady investor sentiment despite broader market volatility.
Also Read: India Sees Dividend Payouts from Leading Companies on August 14
Financial Insights
Gem Aromatics specializes in manufacturing essential oils, aroma chemicals, and value-added derivatives, catering to both domestic and global markets. The company plans to allocate approximately USD 16.8 million (₹140 crore) from the fresh issue proceeds towards debt repayment, improving its balance sheet. Remaining funds will support general corporate purposes.
As of June 2025, Gem Aromatics reported consolidated borrowings of about USD 31 million (₹259.8 crore). With the fresh issue proceeds, the company aims to reduce leverage, improve liquidity, and strengthen long-term growth prospects.
Industry experts suggest that the IPO timing aligns with growing global demand for natural and synthetic specialty ingredients, a segment where India holds significant competitive advantages due to cost efficiency and raw material availability.
Growth Strategy
The company currently offers 70 products across categories including mint and derivatives, clove derivatives, phenols, and other specialty ingredients through three manufacturing facilities. Expansion of production capacity and focus on sustainability remain key pillars of its growth strategy.
READ MORE ON
